The foremost gathering of CEOs of international and local pharmaceutical producers, distributors and retailers

16 - 17 May 2017

Corinthia Saint-Petersburg Hotel

Early speaker confirmations 2017 include:

Dmitry Efimov, Senior Vice-President for Russia, CIS and South-Eastern Europe, STADA Arzneimittel AG
Dmitry Efimov

Senior Vice-President for Russia, CIS and South-Eastern Europe

STADA Arzneimittel AG

Naira Adamian, General Director, Sanofi Russia
Naira Adamian

General Director

Sanofi Russia

Marwan Akar, Vice-President and Managing Director, MSD Russia
Marwan Akar

Vice-President and Managing Director

MSD Russia

Nenad Pavletic, General Manager, Roche Moscow
Nenad Pavletic

General Manager

Roche Moscow

Elena Kartasheva, General Manager, Abbott Russia
Elena Kartasheva

General Manager

Abbott Russia

Mariam Khubieva, CEO, NacImBio
Mariam Khubieva

CEO

NacImBio

Anna Yarvits, SVP General Manager, Teva Russia & CIS
Anna Yarvits

SVP General Manager

Teva Russia & CIS

Ekaterina Pogodina, Executive Director, Janssen (Pharma division of Johnson & Johnson)
Ekaterina Pogodina

Executive Director

Janssen (Pharma division of Johnson & Johnson)

Iskra Reic, Vice-President AstraZeneca Russia & Eurasia, General Director, AstraZeneca Russia
Iskra Reic

Vice-President AstraZeneca Russia & Eurasia, General Director

AstraZeneca Russia

Anthony Wong, General Manager, AbbVie in Russia, Ukraine and CIS
Anthony Wong

General Manager

AbbVie in Russia, Ukraine and CIS

Aleksandr Sokolov, General Director, GSK Russia
Aleksandr Sokolov

General Director

GSK Russia

Rogier Janssens, General Manger, Merck Biopharma
Rogier Janssens

General Manger

Merck Biopharma

Alexander Kuzin, Managing Director, NovaMedica
Alexander Kuzin

Managing Director

NovaMedica

Andrey Odabashian, Head of Legal Services to Pharmaceutical Companies, PwC Legal
Andrey Odabashian

Head of Legal Services to Pharmaceutical Companies

PwC Legal

Vladimir Khristenko, President, Nanolek
Vladimir Khristenko

President

Nanolek

Dmitriy Borisov, Commercial Director, Polysan
Dmitriy Borisov

Commercial Director

Polysan

Vladimir Shipkov, Executive Director, AIPM Russia
Vladimir Shipkov

Executive Director

AIPM Russia

Ivan Glushkov, Director of External Affairs Department, STADA CIS
Ivan Glushkov

Director of External Affairs Department

STADA CIS

Eric Noehrenberg, Regional Market Access and Policy Lead, Shire Pharmaceuticals
Eric Noehrenberg

Regional Market Access and Policy Lead

Shire Pharmaceuticals

Dmitry Pogrebinsky, General Director, CV Protek
Dmitry Pogrebinsky

General Director

CV Protek

Dmitry Rozhdestvensky, Deputy Head of Department for Coordination of Formation of Common Market for Drugs and Medical Devices, Department for Technical Regulation and Accreditation, Eurasian Economic Commission
Dmitry Rozhdestvensky

Deputy Head of Department for Coordination of Formation of Common Market for Drugs and Medical Devices, Department for Technical Regulation and Accreditation

Eurasian Economic Commission

Dmitry Schekin, Head of Coordination and Formation of Common Markets of Pharmaceuticals and Medical Products, Department of Technical Regulation and Accreditation, Eurasian Economic Commission
Dmitry Schekin

Head of Coordination and Formation of Common Markets of Pharmaceuticals and Medical Products, Department of Technical Regulation and Accreditation

Eurasian Economic Commission

Viktor Dmitriev, General Director, Association of Russian Pharmaceutical Manufacturers
Viktor Dmitriev

General Director

Association of Russian Pharmaceutical Manufacturers

Alexander Lobakov, Managing Partner, Novus Capital
Alexander Lobakov

Managing Partner

Novus Capital

Sergey Shulyak, General Director, DSM Group
Sergey Shulyak

General Director

DSM Group

Anna Ermolaeva, General Director, AlphaRM
Anna Ermolaeva

General Director

AlphaRM

Nickolai Demidov, General Manager, QuintilesIMS Russia&CIS
Nickolai Demidov

General Manager

QuintilesIMS Russia&CIS

Alina Lavrentieva, Partner, Tax & Legal Services, PwC
Alina Lavrentieva

Partner, Tax & Legal Services

PwC

Timofey Nizhegorodtsev, Head of the Department of Social Control and Trade, Federal Antimonopoly Service (FAS) of the Russian Federation
Timofey Nizhegorodtsev

Head of the Department of Social Control and Trade

Federal Antimonopoly Service (FAS) of the Russian Federation

Stanislav Livanskiy, Head of Economics and Analytics, Federal Budgetary Institution “State Institute of Medicines and Good Practices” (FBI “SIM & GxP”), Ministry of Industry and Trade of Russian Federation
Stanislav Livanskiy

Head of Economics and Analytics

Federal Budgetary Institution “State Institute of Medicines and Good Practices” (FBI “SIM & GxP”), Ministry of Industry and Trade of Russian Federation

Oxana Monge, General Manager, Sanofi Rx Russia and Belarus
Oxana Monge

General Manager

Sanofi Rx Russia and Belarus

Elena Arkhangelskaya, President, NPO Petrovax Pharm
Elena Arkhangelskaya

President

NPO Petrovax Pharm

Pavol Dobrocky, Managing Director, Boehringer Ingelheim Russia
Pavol Dobrocky

Managing Director

Boehringer Ingelheim Russia

Sergey Piven, President, SIA International
Sergey Piven

President

SIA International

Nikolay Borisoglebsky, General Director, Managing Company Santens Logistic Group LLC
Nikolay Borisoglebsky

General Director

Managing Company Santens Logistic Group LLC

Vitaliy  Smerdov, Chairman of the Board of Directors , PharmEco
Vitaliy Smerdov

Chairman of the Board of Directors

PharmEco

The Programme Offers

  • Global development trends in the Pharmaceutical sector
  • Strategic mini-discussions with leaders: innovative initiatives of pharma companies
  • Debates with general directors: positioning the company for further growth
  • Interviews with key regulators of the industry
  • Discussion regarding the advantages, presented by the expansion of territory – Russia within the framework of the Eurasian Economic Union
  • Sector analysis: what can serve as the main driver of growth?
  • Digital revolution – in which areas will digital technology have the most importance for pharmaceutical companies?
  • Focus on cooperation with patients: how to define a relationship model, which will change the future of the pharma sector?
  • Distributors and retailers in debate

And lots more…

 

 

 

View highlights video
from the Russian Pharmaceutical Forum 2016

 

More videos, including interviews with speakers and special reports by Pharmevstnik TV, HERE >>>

collage photo web eng

 

 

 

View Photo Gallery
from the Russian Pharmaceutical Forum 2016

Amongst 600+ PARTICIPANTS:

Abbott Laboratories
AbbVie
Alfa Wassermann
Allergan
Almirall
Amgen
Angelini Francesco
Baxter
Bayer Pharma
Belupo
Berlin-Chemie
Besins Healthcare

Biogen Interntional
Bittner Pharma
Boehringer Ingelheim
Boiron
Bosnalijek
Bristol-Myers Squibb
EGIS
Eisai
Eli Lilly Vostok
Galderma
Glenmark Pharmaceuticals
Hikma Pharmaceuticals

Ipsen
KRKA Pharma
Lupin
Merck
Nanolek
Novo Nordisk
Petrovax Pharm
Ranbaxy
Reckitt Benckiser
Roche
Servier
Shreya Life Sciences

WHY TO ATTEND THE RUSSIAN PHARMACEUTICAL FORUM?

The most important pharmaceutical conference in Russia! Excellent opportunity to meet your key partners in one place

ALES SUSSINGER,

Commercial Director, KRKA FARMA

Sponsors

Supporting organisations & Media partners